trial · primary record
BL-B01D1
Extensive-stage Small-cell Lung Cancer
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 562 |
| Primary completion | 2029-12 |
| Primary endpoint | Overall survival (OS) |
| Registry ID | NCT07502300 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T13:41:27.955Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07502300
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Bl-B01d1 · compound